A Systematic Review of Studies That Aim to Determine Which Outcomes to Measure in Clinical Trials in Children

Background In clinical trials the selection of appropriate outcomes is crucial to the assessment of whether one intervention is better than another. Selection of inappropriate outcomes can compromise the utility of a trial. However, the process of selecting the most suitable outcomes to include can be complex. Our aim was to systematically review studies that address the process of selecting outcomes or outcome domains to measure in clinical trials in children. Methods and Findings We searched Cochrane databases (no date restrictions) in December 2006; and MEDLINE (1950 to 2006), CINAHL (1982 to 2006), and SCOPUS (1966 to 2006) in January 2007 for studies of the selection of outcomes for use in clinical trials in children. We also asked a group of experts in paediatric clinical research to refer us to any other relevant studies. From these articles we extracted data on the clinical condition of interest, description of the method used to select outcomes, the people involved in the selection process, the outcomes selected, and limitations of the method as defined by the authors. The literature search identified 8,889 potentially relevant abstracts. Of these, 70 were retrieved, and 25 were included in the review. These studies described the work of 13 collaborations representing various paediatric specialties including critical care, gastroenterology, haematology, psychiatry, neurology, respiratory paediatrics, rheumatology, neonatal medicine, and dentistry. Two groups utilised the Delphi technique, one used the nominal group technique, and one used both methods to reach a consensus about which outcomes should be measured in clinical trials. Other groups used semistructured discussion, and one group used a questionnaire-based survey. The collaborations involved clinical experts, research experts, and industry representatives. Three groups involved parents of children affected by the particular condition. Conclusions Very few studies address the appropriate choice of outcomes for clinical research with children, and in most paediatric specialties no research has been undertaken. Among the studies we did assess, very few involved parents or children in selecting outcomes that should be measured, and none directly involved children. Research should be undertaken to identify the best way to involve parents and children in assessing which outcomes should be measured in clinical trials.

[1]  Edmund V Capparelli,et al.  Summary Proceedings From the Neonatal Pain-Control Group , 2006, Pediatrics.

[2]  D. Felson,et al.  Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.

[3]  R. Clancy,et al.  Summary proceedings from the neurology group on neonatal seizures. , 2006, Pediatrics.

[4]  T. Boat,et al.  Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. , 1994, The Journal of pediatrics.

[5]  G. Pearson,et al.  Summary Proceedings From the Cardiology Group on Postoperative Cardiac Dysfunction , 2006, Pediatrics.

[6]  D. Altman,et al.  Outcome selection bias in meta-analysis , 2005, Statistical methods in medical research.

[7]  S. Bae,et al.  The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. , 2006, Arthritis and rheumatism.

[8]  D. Isenberg,et al.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. , 2001, Rheumatology.

[9]  Alexander J. Rothman,et al.  Evolution of the biopsychosocial model: prospects and challenges for health psychology. , 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[10]  P. Lachenbruch,et al.  International consensus on preliminary definitions of improvement in adult and juvenile myositis. , 2004, Arthritis and rheumatism.

[11]  W. Carlo,et al.  Analgesia and anesthesia for neonates: study design and ethical issues. , 2005, Clinical therapeutics.

[12]  G. Guyatt,et al.  Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. , 1997, The European respiratory journal.

[13]  M. Essink‐bot,et al.  Reliability and validity of the short form of the child health questionnaire for parents (CHQ-PF28) in large random school based and general population samples , 2004, Journal of Epidemiology and Community Health.

[14]  M. Clarke,et al.  Evaluating maternity care: a core set of outcome measures. , 2007, Birth.

[15]  R. Nosadini,et al.  Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.

[16]  Linda S. Deal,et al.  Age-Specific Questionnaires Distinguish GERD Symptom Frequency and Severity in Infants and Young Children: Development and Initial Validation , 2005, Journal of pediatric gastroenterology and nutrition.

[17]  B. Short,et al.  Summary Proceedings From the Cardiology Group on Cardiovascular Instability in Preterm Infants , 2006, Pediatrics.

[18]  J. Osborne,et al.  Towards an international consensus on definitions and standardised outcome measures for therapeutic trials (and epidemiological studies) in West syndrome , 2001, Brain and Development.

[19]  Ellen Leibenluft,et al.  Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder : Report of a Consensus , 2004 .

[20]  A. Lewis Group Child Interviews as a Research Tool , 1992 .

[21]  D. Wade,et al.  Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. , 2000, Stroke.

[22]  G. Molenberghs,et al.  A perspective on surrogate endpoints in controlled clinical trials , 2004, Statistical methods in medical research.

[23]  D. DeMets,et al.  Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.

[24]  P. Lachenbruch,et al.  Defining Clinical Improvement in Adult and Juvenile Myositis. , 2003, The Journal of rheumatology.

[25]  W. LaFrance,et al.  Nonepileptic seizures treatment workshop summary , 2006, Epilepsy & Behavior.

[26]  J. Osborne,et al.  A Proposal for Case Definitions and Outcome Measures in Studies of Infantile Spasms and West Syndrome: Consensus Statement of the West Delphi Group , 2004, Epilepsia.

[27]  Emma Pitchforth,et al.  Delphi method and nominal group technique in family planning and reproductive health research , 2006, Journal of Family Planning and Reproductive Health Care.

[28]  K. Minden,et al.  The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. , 2005, Arthritis and rheumatism.

[29]  Mike Clarke,et al.  Standardising outcomes for clinical trials and systematic reviews , 2007, Trials.

[30]  A. Griffiths,et al.  A Review of Activity Indices and End Points for Clinical Trials in Children with Crohn's Disease , 2005, Inflammatory bowel diseases.

[31]  S. Leeder,et al.  The asthma health outcome indicators study , 1996, Australian and New Zealand journal of public health.

[32]  R. Holloway,et al.  Clinical trial end points: on the road to nowhere? , 2002, Neurology.

[33]  L. Rider Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. , 2002, Rheumatic diseases clinics of North America.

[34]  D. Altman,et al.  Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors , 2005, BMJ : British Medical Journal.

[35]  Norman Crolee Dalkey,et al.  An experimental study of group opinion , 1969 .

[36]  P. Williamson,et al.  Bias in meta‐analysis due to outcome variable selection within studies , 2000 .

[37]  B. Leroux,et al.  Issues in design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children. , 2002, Controlled clinical trials.

[38]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[39]  P. Pharoah Impairment, disability, and handicap. , 1990, Archives of disease in childhood.

[40]  D. Mattison,et al.  The Newborn Drug Development Initiative , 2006, Pediatrics.

[41]  W. Kuis,et al.  Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. , 2003, Rheumatology.

[42]  H. Kraemer,et al.  Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  P. Tugwell,et al.  OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. , 1993, The Journal of rheumatology.

[44]  C. Oddis Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies , 2005, Current rheumatology reports.

[45]  N. Finer,et al.  Summary Proceedings From the Apnea-of-Prematurity Group , 2006, Pediatrics.